CD163 and liver cancer: Analysis using the TIMER2.0 database revealed no significant correlation between FABP5 expression and the M1 macrophage marker iNOS in liver cancer but showed a significant positive correlation with the M2 markers CD163 and CD206 (Figure 3B).